Trial Profile
A phase III clinical trial of controlled-release zaleplon in patients with insomnia.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 23 Aug 2012
Price :
$35
*
At a glance
- Drugs Zaleplon (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- 23 Aug 2012 New trial record